Oesophageal cancer is an increasingly common disease in the UK. Sadly, the
overall results of treatment remain poor with overall 5 year survival of ap
proximately 10%. More than 50% of patients receive purely palliative care f
rom the outset. Of those having potentially curative treatment, 40% will no
t survive the first year and 70% will not survive 5 years. Good quality pal
liation is, therefore, required for the majority of patients.